Back to NewEdge Advisors, LLC NewEdge Advisors, LLC

OCULOCUL
Showing 8 of 31 quarters

Position history for NewEdge Advisors, LLCNewEdge Advisors, LLC's holdings in OCULAR THERAPEUTIX INC

NewEdge Advisors, LLC holds 16,725 shares of OCUL (OCULAR THERAPEUTIX INC), worth $164,240 as of 2026-Q2. The position was increased (+21.7% shares). OCUL represents 0.0% of NewEdge Advisors, LLC's portfolio.

Current Value

$164,240

Current Shares

16,725

Total Value Change

+$151,364

Total Shares Change

+15,245

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
16,725
+21.7%
$164,2400.0%$9.82
27
2026-Q1
Increased
13,746
+1274.6%
$116,4290.0%$10.76
35
2025-Q4
Unchanged
1,000
0.0%
$12,1400.0%$12.20
0
2025-Q3
Decreased
1,000
-32.4%
$11,6900.0%$12.53
0
2025-Q2
Unchanged
1,480
0.0%
$13,7340.0%$9.22
0
2025-Q1
Unchanged
1,480
0.0%
$10,8480.0%$7.58
0
2024-Q4
Unchanged
1,480
0.0%
$12,6390.0%$8.35
0
2024-Q3
Unchanged
1,480
0.0%
$12,8760.0%$8.68
0

Other major holders of OCUL: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used